1. Home
  2. YHC vs ONCO Comparison

YHC vs ONCO Comparison

Compare YHC & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YHC
  • ONCO
  • Stock Information
  • Founded
  • YHC 2021
  • ONCO 2018
  • Country
  • YHC United States
  • ONCO United States
  • Employees
  • YHC N/A
  • ONCO N/A
  • Industry
  • YHC Beverages (Production/Distribution)
  • ONCO Biotechnology: Pharmaceutical Preparations
  • Sector
  • YHC Consumer Staples
  • ONCO Health Care
  • Exchange
  • YHC Nasdaq
  • ONCO Nasdaq
  • Market Cap
  • YHC 1.4M
  • ONCO 1.8M
  • IPO Year
  • YHC N/A
  • ONCO 2022
  • Fundamental
  • Price
  • YHC $1.27
  • ONCO $0.08
  • Analyst Decision
  • YHC Strong Buy
  • ONCO
  • Analyst Count
  • YHC 1
  • ONCO 0
  • Target Price
  • YHC $175.00
  • ONCO N/A
  • AVG Volume (30 Days)
  • YHC 3.4M
  • ONCO 44.4M
  • Earning Date
  • YHC 05-13-2025
  • ONCO 06-10-2025
  • Dividend Yield
  • YHC N/A
  • ONCO N/A
  • EPS Growth
  • YHC N/A
  • ONCO N/A
  • EPS
  • YHC N/A
  • ONCO N/A
  • Revenue
  • YHC $2,449,906.00
  • ONCO $1,870,605.00
  • Revenue This Year
  • YHC $69.97
  • ONCO N/A
  • Revenue Next Year
  • YHC $403.29
  • ONCO N/A
  • P/E Ratio
  • YHC N/A
  • ONCO N/A
  • Revenue Growth
  • YHC 68.83
  • ONCO N/A
  • 52 Week Low
  • YHC $1.21
  • ONCO $0.05
  • 52 Week High
  • YHC $98.00
  • ONCO $14.00
  • Technical
  • Relative Strength Index (RSI)
  • YHC N/A
  • ONCO 48.88
  • Support Level
  • YHC N/A
  • ONCO $0.07
  • Resistance Level
  • YHC N/A
  • ONCO $0.08
  • Average True Range (ATR)
  • YHC 0.00
  • ONCO 0.02
  • MACD
  • YHC 0.00
  • ONCO 0.00
  • Stochastic Oscillator
  • YHC 0.00
  • ONCO 12.04

About YHC LQR House Inc. Common Stock

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Share on Social Networks: